Safety Monitoring of Medicinal Products: Guidelines for Setting Up and Running a Pharmacovigilance Centre
(2000; 28 pages) [French]
Table des matières
Afficher le documentINTRODUCTION
Afficher le document1. WHY PHARMACOVIGILANCE?
Afficher le document2. DEFINITION AND AIMS
Ouvrir ce répertoire et afficher son contenu3. HOW TO START A PHARMACOVIGILANCE CENTRE
Ouvrir ce répertoire et afficher son contenu4. REPORTING OF ADVERSE DRUG REACTIONS
Ouvrir ce répertoire et afficher son contenu5. SPECIAL ISSUES IN REPORTING
Fermer ce répertoire6. PRACTICALITIES IN THE ORGANISATION OF A PHARMACOVIGILANCE CENTRE
Afficher le document6.1 Staff
Afficher le document6.2 Useful equipment (includes)
Afficher le document6.3 Continuity
Afficher le document6.4 Advisory Committees
Afficher le document6.5 Information service
Afficher le document6.6 Communications
Afficher le document6.7 Poison Control and Drug Information Centres
Ouvrir ce répertoire et afficher son contenu7. ASSESSMENT OF CASE REPORTS
Ouvrir ce répertoire et afficher son contenu8. USE OF THE DATA
Ouvrir ce répertoire et afficher son contenu9. RELATIONS WITH OTHER PARTIES
Afficher le document10. OTHER SOURCES OF INFORMATION
Afficher le document11. FUNDING
Afficher le documentREFERENCES
Afficher le documentGLOSSARY
Afficher le documentCAUSALITY CATEGORIES
Afficher le documentWHO CONTACTS
 

6.7 Poison Control and Drug Information Centres

Poison control and drug information centres have much in common with pharmacovigilance centres, both in organisation and from a scientific point of view. If pharmacovigilance is started in a country where a poison control or drug information centre is already in place it may be efficient to develop the pharmacovigilance system in conjunction with it. Expensive facilities such as secretariat, computer resources and library services can be shared.

In any case close collaboration between these organisations is desirable.

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013